RECRUITING

Treatment for Sacroiliac Joint Pain Using Platelet-rich Plasma (PRP) Versus Steroid/Anesthetic

Talk to us

Conditions

Low Back PainSacroiliac Joint Synovitis

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to determine if platelet-rich plasma is superior to steroid/anesthetic for the treatment of sacroiliac joint pain.

Official Title

Treatment for Sacroiliac Joint Pain Using Platelet-rich Plasma (PRP) Regenerative Therapy: A Randomized Controlled Trial in Comparison With Steroid/Anesthetic Injection With Advanced MR Analysis

Quick Facts

Study Start:2020-02-22
Study Completion:2025-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05121961

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adult (\>18 y/o) males and females referred for therapeutic injection to the investigators spine interventional service by a physiatrist or pain anesthesiologist with a clinical diagnosis of SIJ pain confirmed by history
  2. * 50% or greater reduction in pain by a diagnostic anesthetic block using no more than 1.5 cc 2% lidocaine performed under imaging guidance by a pain interventionalist (PM\&R, Pain Anesthesia, or Neuroradiology Spine Intervention).
  3. * Baseline pain must be \>/=4 by numeric rating scale (NRS), at least 6 weeks in chronicity, and must not be multi-factorial (related to radiculopathy or axial pain localizing elsewhere) by physical examination or confounding medical history (infection, inflammatory spondyloarthropathy, or osseous metastatic disease).
  1. * SIJ steroid treatment within the prior 6 months.
  2. * Patients with a history of infection currently on antibiotic therapy
  3. * Usage of systemic immunosuppressants
  4. * Pregnancy

Contacts and Locations

Study Contact

Ghazaleh Safazadeh
CONTACT
801-585-1021
Ghazaleh.Safazadeh@hsc.utah.edu
Suyi Niu
CONTACT
801-585-1021
Suyi.Niu@hsc.utah.edu

Principal Investigator

Miriam Peckham, MD
PRINCIPAL_INVESTIGATOR
University of Utah

Study Locations (Sites)

University of Utah
Salt Lake City, Utah, 84132
United States
Veterans Administration Salt Lake City Health Care System
Salt Lake City, Utah, 84148
United States

Collaborators and Investigators

Sponsor: University of Utah

  • Miriam Peckham, MD, PRINCIPAL_INVESTIGATOR, University of Utah

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-02-22
Study Completion Date2025-06-30

Study Record Updates

Study Start Date2020-02-22
Study Completion Date2025-06-30

Terms related to this study

Additional Relevant MeSH Terms

  • Low Back Pain
  • Sacroiliac Joint Synovitis